WuXi Biologics

Pharmaceuticals, Biotechnology and Life Sciences

Targets set1.5°CNet-Zero: Targets set

SBTI ID

40012689

Informations générales

Localisation

China

Asia

Secteur d'activité

Pharmaceuticals, Biotechnology and Life Sciences

Type d'organisation

Corporate

Dernière mise à jour

21/08/2025

Objectifs à court terme (Near-Term)
Engagement de réduction des émissions à horizon 2034

Statut

Targets set

Classification

1.5°C

Année cible

2034

Progression vers l'objectif58%
2015 (année de référence)2034
Objectifs à long terme (Long-Term)
Engagement de réduction des émissions à horizon 2050

Statut

Targets set

Classification

1.5°C

Année cible

2050

Progression vers l'objectif31%
2015 (année de référence)2050
Description complète des objectifs

Overall Net-Zero Target: WuXi Biologics (Cayman) Inc. commits to reach net-zero greenhouse gas emissions across the value chain by 2050. Near-Term Targets: WuXi Biologics (Cayman) Inc. commits to reduce absolute scope 1 and 2 GHG emissions 58.8% by 2034 from a 2024 base year. WuXi Biologics (Cayman) Inc. also commits to reduce scope 3 GHG emissions covering purchased goods and services 63.8% per kg of product produced within the same timeframe. Long-Term Targets: WuXi Biologics (Cayman) Inc. commits to reduce absolute scope 1 and 2 GHG emissions 90% by 2050 from a 2024 base year. WuXi Biologics (Cayman) Inc. also commits to reduce absolute scope 3 GHG emissions covering purchased goods and services, capital goods, fuel and energy related activities, upstream transportation and distribution, waste generated in operations and employee commuting 90% within the same timeframe.

Net-Zero

Statut

Targets set

Année cible

2050

Progression31%
Classification détaillée

The targets covering greenhouse gas emissions from company operations (scopes 1 and 2) are consistent with reductions required to keep warming to 1.5°C

Identifiants

ISIN

KYG970081173

Source : Science Based Targets initiative | Données publiques